HTG Expands Therapeutics Team
Christina M. Carruthers, Ph.D. Joins as Vice President of Target Strategy and Early Development TUCSON, Ariz. , April 13, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide
- Category:
- Press Releases